BioLineRx annual operating expenses
2021
2022
2023
2024
2025
BioLineRx Operating Expenses Growth & History (BLRX)
BioLineRx's operating expenses was $11.2M for fiscal 2025.
View full BioLineRx company overviewBioLineRx annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.2M | −$28.8M | −71.97% |
| 2024 | 2024-12-31 | $40.1M | −$10.7M | −21.10% |
| 2023 | 2023-12-31 | $50.8M | $21.6M | +74.24% |
| 2022 | 2022-12-31 | $29.2M | $4.4M | +17.68% |
| 2021 | 2021-12-31 | $24.8M | — | — |
BioLineRx quarterly operating expenses
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.8M | $1.3M | +50.22% |
| Q1 2026 | 2026-03-31 | $3.4M | $774,000 | +29.63% |
| Q4 2025 | 2025-12-31 | $3.5M | — | — |
| Q3 2025 | 2025-09-30 | $2.5M | — | — |
| Q2 2025 | 2025-06-30 | $2.5M | −$7.7M | −75.31% |
| Q1 2025 | 2025-03-31 | $2.6M | — | — |
| Q2 2024 | 2024-06-30 | $10.3M | $354,000 | +3.57% |
| Q2 2023 | 2023-06-30 | $9.9M | — | — |
BioLineRx operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, BioLineRx's operating expenses decreased from $24.8M to $11.2M, a change of −$13.5M. The latest reported quarter, Q2 2026, shows $3.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioLineRx source filings ↗